Meant something to Dr B, who is a professional in his field. Meant enough to spend more money on it. My comments are based on facts from the company; your's is simply based on gut feel.
Company also commented...
Cellceutix is extremely proud of the Phase 2 Prurisol results. Simply put, the drug’s efficacy compares favorably with many current and various types of treatments for psoriasis (see the study linked to below), including apremilast or Otezla®, which is the leading oral FDA approved anti-psoriasis drug. It is interesting to do a side-by-side comparison between the two based on publicly available literature, and it could be argued that Prurisol performs on par with, if not better than, Otezla® at the identical stage of development
News 
Market Data 
Discover 
